ArticleJournal of experimental & clinical cancer research : CR2026
Targeting the DNA-repair chromatin-modifier protein SMYD3 as a novel epigenetics-based therapy for gastric cancer.
Katia De Marco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.